Vertex Pharmaceuticals Incorporated
IT ˙ BIT ˙ US92532F1003
366,30 € ↓ -1,30 (-0,35%)
2026-06-03
AKTIENPREIS
SecurityIT:1VRTX / Vertex Pharmaceuticals Incorporated
InstitutionBokf, Na
Latest Disclosed Ownership5,935 shares
Latest Disclosed Value $ 2,650,215
Bokf, Na reports 1.16% increase in ownership of 1VRTX / Vertex Pharmaceuticals Incorporated

On May 8, 2026 - Bokf, Na filed a 13F-HR form disclosing ownership of 5,935 shares of Vertex Pharmaceuticals Incorporated (IT:1VRTX) valued at $2,252,926 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 5,867 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 1.16% during the quarter. The current value of the position is $2,173,990 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F VERTEX PHARMACEUTICALS common 92532F100 5,935 68 1.16 2,650 -0.34 0.0312
2026-02-03 2025-12-31 13F VERTEX PHARMACEUTICALS common 92532F100 5,867 -1,171 -16.64 2,660 -3.52 0.0407
2025-11-13 2025-09-30 13F VERTEX PHARMACEUTICALS common 92532F100 7,038 -1,216 -14.73 2,756 -24.99 0.0415
2025-08-12 2025-06-30 13F VERTEX PHARMACEUTICALS common 92532F100 8,254 1,154 16.25 3,675 6.74 0.0595
2025-05-13 2025-03-31 13F VERTEX PHARMACEUTICALS common 92532F100 7,100 -685 -8.80 3,442 7.97 0.0609
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS common 92532F100 7,785 -68 -0.87 3,188 -10.47 0.0539
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS common 92532F100 7,853 -150 -1.87 3,562 -5.07 0.0632
2024-08-08 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 8,003 -2,229 -21.78 3,751 -12.81 0.0673
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 10,232 -9,274 -47.54 4,302 -45.79 0.0783
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 19,506 -100 -0.51 7,937 11.79 0.1554
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 19,606 394 2.05 7,100 5.01 0.1565
2023-08-21 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 19,212 -769 -3.85 6,761 7.39 0.1377
2023-05-11 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 19,981 -3,157 -13.64 6,295 -5.78 0.1317
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 23,138 16,308 238.77 6,682 237.94 0.1233
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,830 -78 -1.13 1,977 1.59 0.0400
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,908 -4,668 -40.32 1,946 -35.58 0.0373
2022-05-13 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,576 -12 -0.10 3,021 18.70 0.0498
2022-03-11 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 11,588 -1,445 -11.09 2,545 7.66 0.0394
2021-11-10 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 13,033 -3,792 -22.54 2,364 -34.61 0.0406
2021-04-21 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 16,825 -25,204 -59.97 3,615 -63.61 0.0657
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 42,029 -1,504 -3.45 9,933 -16.16 0.1895
2020-10-30 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 43,533 -5,090 -10.47 11,847 -16.07 0.2602
2020-08-12 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 48,623 -131 -0.27 14,116 21.68 0.3320
2020-05-13 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 48,754 4,737 10.76 11,601 20.38 0.3342
2020-02-12 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 44,017 13,505 44.26 9,637 86.44 0.2178
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 30,512 -13,149 -30.12 5,169 -35.44 0.1245
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 43,661 4,459 11.37 8,007 11.04 0.1924
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 39,202 4,514 13.01 7,211 25.45 0.1726
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 34,688 20,469 143.96 5,748 109.78 0.1644
2018-11-13 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 14,219 7,780 120.83 2,740 150.23 0.0688
2018-08-13 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 6,439 2,637 69.36 1,095 76.90 0.0295
2018-05-14 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,802 1,946 104.85 619 122.66 0.0176
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,856 -359 -16.21 278 -17.26 0.0077
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,215 -256 -10.36 336 5.33 0.0098
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,471 -210 -7.83 319 57.14 0.0100
2013-11-12 2013-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,681 120 4.69 203 -0.98 0.0074
2013-08-14 2013-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,561 2,561 205 0.0077
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.